Characteristic | DLE (n = 12)* | Controls (n = 30) |
---|---|---|
Female sex, No. of patients (%) | 6 (50) | 10 (33) |
Race, white, No. of patients (%) | 12 (100) | 30 (100) |
Age, median (range), y | Â | Â |
At radiotherapy | 69 (55-82) | 65 (51-86) |
At initial DLE symptoms | 47 (9-79) | - |
At DLE diagnosis | 45 (11-79) | - |
DLE diagnosis | Â | Â |
Established before radiotherapy, No. of patients (%) | 9 (75) | - |
Established after radiotherapy, No. of patients (%) | 3 (25) | -- |
Time between DLE diagnosis and radiotherapy, median (range), y | Â | -- |
Diagnosis first | 9.0 (2.2-27.0) | - |
Radiotherapy first | 3.1 (1.7-6.3) | - |
American College of Rheumatology systemic lupus erythematosus characteristic, No. of patients (%) | Â | Â |
Discoid rash | 12 (100) | - |
Photosensitivity | 9 (75) | - |
Primary tumor location, No. of patients (%) | Â | Â |
Prostate | 4 (33) | 8 (26) |
Breast | 2 (17) | 4 (13) |
Lung | 2 (17) | 8 (26) |
Oral | 2 (16) | 6 (20) |
Anus | 1 (8) | 2 (6) |
Bladder | 1 (8) | 2 (6) |